Psychedelics and the Treatment of Nicotine Dependence: What Is Known?

This webinar delves into the processes believed to drive psilocybin’s therapeutic impact—from emotional regulation and brain plasticity to the role of mystical experiences—and takes a critical look at the scientific evidence that supports its promise for nicotine cessation. Thoughtful, balanced, and grounded in clinical relevance, this presentation helps clarify both the potential and the current limitations of psychedelic treatments as they make their way into behavioral health.